Abstract
Recent studies on cancer stem cells (CSCs), a special subpopulation of tumor cells, promote our understanding of tumorigenesis, neovascularization, invasion, drug resistance and tumor recurrence, which establishes new concepts for cancer diagnosis and treatment. Therefore, the biological features and behaviors of CSCs have become an exciting frontier of cancer research. CSCs initiate tumor neovascularization and promote invasion with yet to be defined mechanisms. In this review, we provide evidence for the role of CSCs in tumor vascularization and discuss the potential mechanisms and therapeutic significance based on the interaction between CSCs and their vascular niches.
Keywords: Angiogenesis, cancer stem cells, microvascular niches, transdifferentiation, vasculogenic mimicry, acute myeloid, AML, tumor, tumorigenesis, metastasis, neovascularization, vascularization, tubulogenesis, Chemokines, lymphoma, multiple myeloma, oncogene, nephroblastoma, Anti-angiogenic drugs
Current Molecular Medicine
Title: Cancer Stem Cells Switch on Tumor Neovascularization
Volume: 11 Issue: 1
Author(s): Y.-F. Ping and X.-W. Bian
Affiliation:
Keywords: Angiogenesis, cancer stem cells, microvascular niches, transdifferentiation, vasculogenic mimicry, acute myeloid, AML, tumor, tumorigenesis, metastasis, neovascularization, vascularization, tubulogenesis, Chemokines, lymphoma, multiple myeloma, oncogene, nephroblastoma, Anti-angiogenic drugs
Abstract: Recent studies on cancer stem cells (CSCs), a special subpopulation of tumor cells, promote our understanding of tumorigenesis, neovascularization, invasion, drug resistance and tumor recurrence, which establishes new concepts for cancer diagnosis and treatment. Therefore, the biological features and behaviors of CSCs have become an exciting frontier of cancer research. CSCs initiate tumor neovascularization and promote invasion with yet to be defined mechanisms. In this review, we provide evidence for the role of CSCs in tumor vascularization and discuss the potential mechanisms and therapeutic significance based on the interaction between CSCs and their vascular niches.
Export Options
About this article
Cite this article as:
Ping Y.-F. and Bian X.-W., Cancer Stem Cells Switch on Tumor Neovascularization, Current Molecular Medicine 2011; 11 (1) . https://dx.doi.org/10.2174/156652411794474383
DOI https://dx.doi.org/10.2174/156652411794474383 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Bioactive Metabolites from Pathogenic and Endophytic Fungi of Forest Trees
Current Medicinal Chemistry Potential Roles of HDAC Inhibitors in Mitigating Ischemia-induced Brain Damage and Facilitating Endogenous Regeneration and Recovery
Current Pharmaceutical Design Pharmacophores for Ligand Recognition and Activation / Inactivation of the Cannabinoid Receptors
Current Pharmaceutical Design Long Non-Coding RNAs As Epigenetic Regulators in Cancer
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Drug Delivery Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Natural and Synthetic Agents Targeting Inflammation and Angiogenesis for Chemoprevention of Prostate Cancer
Current Cancer Drug Targets Targeting Transient Receptor Potential Channels in Cardiometabolic Diseases and Myocardial Ischemia Reperfusion Injury
Current Drug Targets Brain Tumour Stem Cells: Implications for Cancer Therapy and Regenerative Medicine
Current Stem Cell Research & Therapy Cannabinoids as Analgesic Agents: Evidence from In Vivo Studies
Current Neuropharmacology Inhibitors of the Proteolytic Activity of Urokinase Type Plasminogen Activator
Current Pharmaceutical Design Nanotechnology and Atherosclerosis Imaging: Emerging Diagnostic and Therapeutic Applications
Recent Patents on Cardiovascular Drug Discovery Gold Nanoparticles - Synthesis and Applications in Cancer Management
Recent Patents on Materials Science CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer
Current Cancer Drug Targets Editorial [Hot Topic: Target Therapy in Brain Tumours and Metastases (Guest Editors: M. Caraglia and R. Addeo)]
Current Cancer Drug Targets Notch Signaling: A Potential Therapeutic Target in Prostate Cancer
Current Cancer Drug Targets Prognostic and Predictive Biomarkers in Colorectal Cancer. From the Preclinical Setting to Clinical Practice
Current Cancer Drug Targets Targeting the Multifaceted HuR Protein, Benefits and Caveats
Current Drug Targets Redox-active and Redox-silent Compounds: Synergistic Therapeutics in Cancer
Current Medicinal Chemistry Ferroptosis Inducers for Prostate Cancer Therapy
Current Medicinal Chemistry